Egyptian Drug Authority · Egypt
DEA-EG-2026-0045
Tier 1 · Regulator-publishedClass IIRecallStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(45) For 2026
- Date issued
- Jun 2026
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- Mepahisttablets
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- 1320924 · 770424 · 1470124 · 1101123 · 580324
- Expiry dates
- Not published with the notice
- Action type
- Recall
- Classification
- Class II as issued
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- Mepahist tablets
580324و1101123و1470124و770424و1320924و
2920125و3060325و780823
Mepaco
وذلـــك طبقا لقرار اللجنة الفنية لمراقبة الأدوية بان يتم وقف
تداول الكميات المتداولة من هذه التشغيلات من الصنف
الموضح بعاليه
وقف تداول التشغيلات المنوه عنها بعاليه وذلك
وفقا لقرار اللجنه الفنيه
في حالة الشك في المستحضر الصيدلى يتمالرجوع
إلى هيئة الدواء المصرية سواء بالإتصال بالخط
الساخن 15301او الموقع الإلكترونى الخاص بالهيئة.
مايو2026
اسمالمستحضر
الشركة المصنعة
سبب التحذير
الإجراءات
التصحيحية
نصائح
للمستهلكين
منشور
سحب
هذا التنبية خاص بالتشغيلات الواردة في المنشور فقط ولا ينطبق على تداول
المستحضر بشكل عام
رقم التشغيلةOriginal language: ar
- Notice text in English
- Notice. Mepahist tablets, of Mepaco, batches 580324, 1101123, 1470124, 770424, 1320924, 2920125, 3060325 and 780823. By decision of the technical committee for the control of medicines, circulation of the quantities in circulation from these batches is to stop.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 3
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- 28503cb3af41c69a3a79e6522ef60ca8ce978aa85785db18f2ebe21587d5f2d9SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:49:54 UTC
Cite this record
Drug Eye Africa (2026). DEA-EG-2026-0045: Mepahisttablets — Recall, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2026/dea-eg-2026-0045Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.